CD40-CD40L interactions in platelet activation

Thrombosis and Haemostasis

Volumn 93, Issue 6, 2005, Pages 1011-1012

  Davì, Giovanni ^a   Ferroni, Patrizia ^b  

^a UNIVERSITY OF CHIETI   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; CD40 LIGAND; CD40 LIGAND MONOCLONAL ANTIBODY;

ANTIGEN BINDING; ANTIPHOSPHOLIPID SYNDROME; BLEEDING TIME; CLINICAL TRIAL; EDITORIAL; HEMOSTASIS; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; HYPERIMMUNOGLOBULINEMIA M; IMMUNOTHERAPY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SIDE EFFECT; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBOEMBOLISM;

ANIMALS; ANTIGENS, CD40; CD40 LIGAND; HUMANS; MICE; MICE, KNOCKOUT; PLATELET ACTIVATION;

EID: 20444480237     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH05-04-0270     Document Type: Editorial

References (14)

1. Korthauer U, Graf D, Mages HW et al. Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature 1993; 361: 539-41.
2. Novo S, Basili S, Tantillo R et al. Soluble CD40L and cardiovascular risk in asymptomatic low-grade carotid stenosis. Stroke 2005; 36: 673-5.
3. Falco A, Romano M, Iapichino L et al. Increased soluble CD40 ligand levels in cystic fibrosis. J Thromb Haemost 2004; 2: 557-60.
4. Roselli M, Mineo TC, Basili S et al. Soluble CD40 ligand plasma levels in lung cancer. Clin Cancer Res 2004; 10: 610-4.
5. Andre P, Prasad KS, Denis CV et al. CD40L stabilizes arterial thrombi by a β3 integrin-dependent mechanism. Nat Med 2002; 8: 247-52.
6. Henn V, Slupsky JR, Gräfe M et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 1998; 391: 591-4.
7. Prasad KS, Andre P, Yan Y et al. The platelet CD40L/GP IIb-IIIa axis in atherothrombotic disease. Curr Opin Hematol 2003; 10: 356-61.
8. Inwald DP, McDowall A, Peters MJ et al. CD40 is constitutively expressed on platelets and provides a novel mechanism for platelet activation. Circ Res 2003; 92: 1041-8.
9. Henn V, Steinbach S, Büchner K et al. The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40. Blood 2001; 98: 1047-54.
10. Prasad KS, Andre P, He M et al. Soluble CD40 ligand induces beta3 integrin tyrosine phosphorylation and triggers platelet activation by outside-in signaling. Proc Natl Acad Sci USA 2003; 100: 12367-71.
11. Crow AR, Leytin V, Starkey AF et al. CD154 (CD40 ligand)-deficient mice exhibit prolonged bleeding time and decreased shear-induced platelet aggregates. J Thromb Haemost 2003; 1: 850-2.
12. Langer F, Ingersoll SB, Amirkhosravi A et al. The role of CD40 in CD40L- and antibody-mediated platelet activation. Thromb Haemost 2005; 93: 1137-46.
13. Yazdany J, Davis J. The role of CD40 ligand in systemic lupus erythematosus. Lupus 2004; 13: 377-80.
14. Sidiropoulos PI, Boumpas DT. Lessons learned from anti-CD40L treatment in systemic lupus erythematosus patients. Lupus 2004; 13: 391-7.